Treatment Efficiency Report

January 2025-October 2025

ERP Health Verified

Executive Summary

Intrepid Recovery Centers continues to deliver measurable, datadriven outcomes that demonstrate both clinical excellence and strong business value for referral partners. Between January and October 2025, 425 patients engaged in treatment, achieving an exceptional 98% engagement rate and a remarkably low 7% AMA rate, well below the national detox average of 25%. Clinical outcomes show significant improvement across key measures, including 72% reduction in cravings, 53% reduction in depression, 48% reduction in anxiety, and 25% increase in quality of life, outperforming both ERP national and Florida benchmarks. Patient satisfaction remains a cornerstone of care, averaging 4.5/5 across over 1,100+ surveys, reflecting Intrepid’s commitment to compassionate, high-quality, and outcomes-oriented treatment. These results position Intrepid Recovery Centers as a trusted, high-performing partner for referral sources seeking consistent retention, measurable recovery outcomes, and clear ROI.

holistic recovery center florida

All Patient Data

425 patients utilized ERPHealth’s GRO platform between Jan and Oct 2025. 64% identify as male and 36% identify as female. Patient age ranges from 19-72 with 38% falling in the 25-40 age group, 30% in the 41-56 age group, 20% in the 18-24 age group and 12% over 57 years old. Overall, the average length of stay for this group was 30 days.

In-Treatment Patients:

0

Female Patients:

0

Male Patients:

0

Age Range:

19-72

Years Old

Median Age:

40

Years

Avg. Length of Stay:

30

Days

In-Treatment Patients:

0

Female Patients:

0

Male Patients:

0

Age Range:

19-72

Years Old

Median Age:

40

Years Old

Avg. Length of Stay:

30

Days

Age Group Pie Chart

Patient Engagement & Retention

Patient engagement is defined as the percentage of assessments that are completed of the total assigned. ERPHealth’s standard for successful engagement is 70% and Intrepid Recovery Centers achieved an overall engagement rate of 98% with the administration of over 11,000 assessments from Jan-Oct 2025. The engagement rate ranged from 95%, which was achieved in March 2025 to 100%, which was achieved in Jan 2025. Intrepid remained above ERPHealth’s standard for successful engagement in all the months. This excellent engagement rate has directly and positively impacted Intrepid Recovery Centers’s AMA rate, which stands at 7% versus the national average of 25% of patients who leave treatment AMA.

Average Engagement Rate:

0 %

vs ERP Avg: 89%, vs ERP Threshold: 70%

Average AMA Rate:

0 %

vs National Avg: 25%

Total Assessments Completed:

0

Average Engagement Rate:

0 %

vs ERP Avg: 89%, vs ERP Threshold: 70%

Average AMA Rate:

0 %

vs National Avg: 25%

Total Assessments Completed:

0
Engagment Rate Graph

Patient Satisfaction Overview

The patient satisfaction survey is rated on a 1-5 scale (1-Extremely Dissatisfied, 5- Extremely Satisfied). The categories measured are: Cleanliness of Facility, Treatment Groups, Treatment Counselors, Staff Kindness and Overall Experience.

Org Average Star
Patient-Satisfaction

Key Findings

Patient satisfaction is assessed regularly throughout treatment and covers important areas like staff kindness, satisfaction with counselors and groups, the cleanliness of the environment, and the overall experience. Intrepid patient population rated overall satisfaction at a 4.5/5 stars and rated both staff kindness and satisfaction with counselor an excellent 4.6 out of 5 stars.

Patient-Satisfaction

Patient Outcomes

Through routine behavioral health screening and use of that data in clinical intervention for measurement-informed care, Intrepid is moving the needle on overall outcomes. Clinical outcomes for these months reveal the positive impact treatment programs are having for patients.

A. Considering the patient population as a whole, notable outcomes include a 53% decrease in depression and 48% decrease in the anxiety, and an impressive 72% decrease in cravings.

B. When compared to national and state benchmarks, Intrepid patients demonstrated stronger outcomes. Craving score improved by 72% compared to the 57% Florida average, while depression improved by 53% compared to the 43% national average.

0 %

Improvement in Quality Of Life

Key Findings

Intrepid patients have shown exceptional clinical outcomes

  • Cravings Improvement 72% vs 57% ERP Florida avg
  • Depression Improvement 53% vs 43% ERP National avg

Change from Average First Score to Average Last Score

0 %

Improvement in Quality Of Life

0 %

Decrease In Depression

0 %

Decrease In Anxiety

0 %

Decrease In Stress

0 %

Decrease In Craving

Change from Average First Score to Average Last Score

Key Findings

Intrepid patients have shown exceptional clinical outcomes

  • Cravings Improvement 72% vs 57% ERP Florida avg
  • Depression Improvement 53% vs 43% ERP National avg

Symptom Reduction Metrics

Decreased Depression Severity

Instrument Description

The Patient Health Questionnaire (PHQ9) is a multipurpose instrument used for screening, diagnosing, monitoring, and measuring the severity of depression. Patients rate their experience with various symptoms of depression from 0 (not at all) to 3 (nearly every day) when asked how often those symptoms have been bothersome over the previous 2 weeks. Results can range from “minimal depression” to “severe depression”. Generally, a score in the “moderate depression” range (10-14) or above warrants further evaluation.

Decrease-In-Depression
Depression reduction graph

Key Findings

Overall, PHQ-9 scores show a decrease in severity of depression and fell from moderately severe to mild range over a 4-week course of treatment. Separating out female and male patients, female patient depression scores reduced by 58%, while male patient depression scores decreased by 52%.

Anxiety reduction graph

Key Findings

Overall, GAD-7 scores show a decrease in severity of anxiety and fell from moderate to mild range over a 4-week course of treatment. Separating out female and male patients, female patient anxiety scores reduced by 53%, while male patient anxiety scores reduced by 46%.

Decreased Anxiety Severity

Instrument Description

The Generalized Anxiety Disorder scale (GAD-7) is a brief measure for the severity of symptoms of anxiety. Patients are asked to rate their experience with various symptoms of anxiety from 0 (not at all) to 3 (nearly every day) when asked how often these symptoms have been bothersome over the prior 2 weeks. Results can range from “minimal anxiety” to “severe anxiety” and generally a score of 10 or higher, which indicates “moderate” or “severe” anxiety warrants further evaluation.

Decrease In Anxiety

Decreased Stress Severity

Instrument Description

The Perceived Stress Scale (PSS) is a 10-item instrument that helps measure individual levels of stress, including how different situations impact how we feel and how we perceive that stress personally. Patients consider the prior month and rate their experiences with various stressful events on a scale from “=0 (never) to 4 (very often). Results can range from low stress to high perceived stress and scores in the moderate range (14-26) or higher are indicative of the need for further evaluation.

Decrease In Stress
Stress reduction graph

Key Findings

Patient perceived stress scores remained in the moderate stress range during treatment. Comparing by outcomes by gender, female patient stress score reduced by 29% and male patient score reduced by 18% over the 4-week course of treatment.

Cravings reduction graph

Key Findings

Craving scores along with depression, anxiety and stress have reduced over the course of 4 weeks. Female patient craving scores reduced by 69% and male patient scores reduced by 75% over the course of treatment.

Decreased Craving Severity

Instrument Description

The Brief Substance Craving Scale is a 16-item measure that assesses various substance cravings over a 24-hour period. Intensity and frequency of cravings are recorded on a 5-point scale ranging from 0 (not at all) to 4 (extreme/constant/very long). This measure can be used at intake, during treatment to track progress, and upon follow-up after treatment has been completed to monitor risk.

Decrease-In-Cravings

Why Choose Intrepid Recovery Centers?

Exceptional Engagement Rate

98% engagement rate far above the 70% ERP standard and 7% AMA rate ensuring patients stay in care.

Stronger Outcomes

72% ↓ cravings, 53% ↓ depression, 48% ↓ anxiety, 31% ↓ stress, and 25% ↑ quality of life - exceeding national and regional benchmarks

Positive Patient Experience

4.5/5 overall satisfaction across 1,147 surveys. Excellent rating for staff kindness and satisfaction with counselor.

Reduced Referral Risk

Patients are less likely to discharge early and more likely to complete treatment.

Clear ROI for Partners

Healthier, engaged patients = better outcomes, fewer readmissions, and a stronger reputation for your referrals.